Citius Pharmaceuticals, Inc. CTXR Income Statement

Citius pharmaceuticals, inc. (CTXR)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10
Revenues
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses
Research and development
2,015	2,664	2,017	2,766	1,699	2,113	1,737	778	3,439	606	474	190	859	1,411	1,923	381	-200	829	622	415	282	477	0	0	0	437	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
2,258	1,562	1,502	1,456	1,738	1,588	1,773	1,114	1,212	2,346	1,749	1,797	1,383	1,132	1,268	1,464	756	294	241	194	217	293	131	1	49	61	1	0	0	0	0	3	0	0	1	4	5	0
Stock-based compensation - general and administrative
158	220	137	204	203	171	150	124	214	290	178	266	300	241	214	280	115	121	105	163	108	108	470	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Professional Fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	3	8	0	3	2	6	2	1	2	1	8
Total Operating Expenses
4,433	4,447	3,657	4,426	3,641	3,872	3,661	2,017	4,866	3,242	2,402	2,255	2,543	2,784	3,406	2,126	671	1,244	968	773	608	878	602	1	49	499	14	3	9	0	4	6	6	2	2	7	7	8
Operating Loss
-4,433	-4,447	-3,657	-4,426	-3,641	-3,872	-3,661	-2,017	-4,866	-3,242	-2,402	-2,255	-2,543	-2,784	-3,406	-2,126	-671	-1,244	-968	-773	-608	-878	-602	-1	-49	-499	-14	-3	-9	-0	-4	-6	-6	-2	-2	-7	-7	-8
Other Income (Expense)
Other income
0	110	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
12	19	11	25	14	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on extinguishment of liability
-	-	-	-	-	-	-	-	450	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on revaluation of derivative warrant liability
-	-	-	-	-	-	-	-	-	-	143	-133	-179	622	821	-1,485	-197	23	-	-51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (loss) on revaluation of derivative warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	263	60	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
3	3	4	4	4	4	3	3	4	3	784	33	19	13	4	4	0	0	0	0	0	7	19	33	40	35	-	-	-	-	-	-	0	0	0	0	0	0
Total Other Income, Net
8	125	7	21	10	-2	814	-3	445	-3	-640	-167	-199	608	816	-1,489	-197	23	60	-51	263	55	-9	-33	-40	-35	-	-	-	-	-	-	-	-	-	-	-	-
Loss before Income Taxes
-	-	-	-	-	-	-	-	-	-3,246	17,726	-2,422	-2,743	-2,175	-2,589	-3,615	-869	-1,220	-908	-824	-345	-823	-612	-34	-90	-534	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	0	-	-	-	-	-	-
Loss before provision for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15	-4	-10	-1	-5	-6	-7	-2	-2	-7	-7	-9
Income tax benefit
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Loss
-4,424	-4,322	-3,649	-4,405	-3,631	-3,874	-2,846	-2,021	-4,421	-3,246	-3,043	-2,422	-2,743	-2,175	-2,589	-3,615	-869	-1,220	-908	-824	-345	-823	-612	-34	-90	-534	-15	-4	-10	-1	-5	-6	-7	-2	-2	-7	-7	-9
Net Loss Per Share - Basic and Diluted
-0.13	-0.15	-0.15	-0.20	-0.20	-0.22	-0.16	-0.19	-0.44	-0.38	-0.42	-0.48	-0.55	-0.44	-1.15	-0.75	-0.35	-0.04	-1.30	-0.03	-0.01	-0.03	-0.56	0.00	-0.01	-0.03	-	-	-	-	-	-	-	-	-	-	-	-
Weighted Average Common Shares Outstanding
Basic and diluted
34,318	29,197	22,401	22,000	18,481	17,764	13,679	10,677	9,966	8,605	6,985	5,047	4,993	4,903	-27,249	4,844	2,482	34,414	-85,007	32,312	31,147	30,036	-31,735	17,843	17,757	17,757	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per share - basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income (loss) per share - diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Weighted average shares outstanding - basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000
Weighted average shares outstanding - diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000	18,000